Viewing Study NCT04019795



Ignite Creation Date: 2024-05-06 @ 1:24 PM
Last Modification Date: 2024-10-26 @ 1:14 PM
Study NCT ID: NCT04019795
Status: COMPLETED
Last Update Posted: 2019-07-15
First Post: 2019-07-11

Brief Title: Modulated Light Therapy in Participants With Pattern Hair Loss
Sponsor: PhotonMD Inc
Organization: PhotonMD Inc

Study Overview

Official Title: A Prospective Randomized Controlled Double-Blind Study That Evaluates the Safety and Efficacy of Three Active REVIAN Caps Versus a Non-Active REVIAN Cap Sham in Participants With Pattern Hair Loss Androgenic Alopecia
Status: COMPLETED
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: REV-01
Brief Summary: The REVIAN study is designed as a prospective randomized controlled double-blind parallel study to evaluate the efficacy and safety of the REVIAN System in male participants with androgenic alopecia An Active modulated light therapy REVIAN System will be compared to a Placebo Comparator non-active REVIAN System in participants using the device for a daily 10-minute treatment over the course of 26-weeks At each follow-up visit participants will be interviewed to determine if any adverse events AEs were experienced since the previous follow-up visit All participants will be required to complete self-administering scalp hair growth and life quality questionnaires at each follow-up visit Investigators will be required to complete global assessments of scalp hair growth for each enrolled participant at each follow-up visit Macrophotography evaluations will be performed at baseline 8- 16- and 26 weeks for all participants using standard Canfield blinded reviewer Global photographs of superior and vertex scalp will be taken by participants and by PI to be assessed by a blinded reviewer once all photos have been captured for each participant per visit
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None